Compositions and methods of treatment for psoriasis
OwnerAvi Dascaluinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides for a composition comprising a tryptamine based drug that acts as a 5-hydroxytryptamine-1 inhibitor in an amount sufficient to reduce the effects of psoriasis and wherein the composition is formulated for topical or oral administration.
Claims4
A composition for treating psoriasis, the composition comprising a tryptamine based drug that acts as a 5-hydroxytryptamine-1 inhibitor formulated for topical application and in a in a therapeutically effective amount from about 0.01% to about 1% weight and sufficient to reduce the effects of psoriasis.
The composition of claim 2 wherein the tryptamine based drug is selected from the group consisting of rizatriptan, eletriptan, naratriptan, zolmitriptan, frovatriptan, sumatriptan, almotriptan or salts thereof.
A composition for the treatment of psoriasis comprising:
- at least one tryptamine based drug that acts as a 5-hydroxytryptamine-1 inhibitor in a concentration of about 0.01% to about 1%;
- and at least three of the following components selected from the group consisting of
- at least one emollient in a concentration of in a concentration of about 5% to about 60%;
- at least one thickener in a concentration of about 0.5% to about 20%;
- at least one preservative in a concentration of about 0.01% to about 10%;
- at least one moisturizer in a concentration of about 0.01% to about 10%;
- at least one surfactant in a concentration of about 1% to about 20%;
- at least one antimicrobial in a concentration of about 0.01% to about 2%;
- and water from about 2% to 80%
Dependencies are inferred from the claim text.